10 research outputs found

    Submicroscopic placental infection by non-<i>falciparum Plasmodium</i> spp.

    No full text
    <div><p>Background</p><p>Among the <i>Plasmodium</i> species that infect humans, adverse effects of <i>P</i>. <i>falciparum</i> and <i>P</i>. <i>vivax</i> have been extensively studied and reported with respect to poor outcomes particularly in first time mothers and in pregnant women living in areas with unstable malaria transmission. Although, other non-<i>falciparum</i> malaria infections during pregnancy have sometimes been reported, little is known about the dynamics of these infections during pregnancy.</p><p>Methods and findings</p><p>Using a quantitative PCR approach, blood samples collected from Beninese pregnant women during the first antenatal visit (ANV) and at delivery including placental blood were screened for <i>Plasmodium</i> spp. Risk factors associated with <i>Plasmodium spp</i>. infection during pregnancy were assessed as well as the relationships with pregnancy outcomes.</p><p><i>P</i>. <i>falciparum</i> was the most prevalent <i>Plasmodium</i> species detected during pregnancy, irrespective either of parity, of age or of season during which the infection occurred. Although no <i>P</i>. <i>vivax</i> infections were detected in this cohort, <i>P</i>. <i>malariae</i> (9.2%) and <i>P</i>. <i>ovale</i> (5.8%) infections were observed in samples collected during the first ANV. These non-<i>falciparum</i> infections were also detected in maternal peripheral blood (1.3% for <i>P</i>. <i>malariae</i> and 1.2% for <i>P</i>. <i>ovale</i>) at delivery. Importantly, higher prevalence of <i>P</i>. <i>malariae</i> (5.5%) was observed in placental than peripheral blood while that of <i>P</i>. <i>ovale</i> was similar (1.8% in placental blood). Among the non-<i>falciparum</i> infected pregnant women with paired peripheral and placental samples, <i>P</i>. <i>malariae</i> infections in the placental blood was significantly higher than in the peripheral blood, suggesting a possible affinity of <i>P</i>. <i>malariae</i> for the placenta. However, no assoctiation of non-<i>falciparum</i> infections and the pregnancy outcomes was observed</p><p>Conclusions</p><p>Overall this study provided insights into the molecular epidemiology of <i>Plasmodium</i> spp. infection during pregnancy, indicating placental infection by non-<i>falciparum Plasmodium</i> and the lack of association of these infections with adverse pregnancy outcomes.</p></div

    Monthly prevalence of <i>P</i>. <i>falciparum</i> and non-<i>falciparum</i> infections in Beninese pregnant women.

    No full text
    <p>The prevalence of <i>P</i>. <i>falciparum</i> (in red) and non-<i>falciparum</i> (in blue) infections detected in pregnant at the enrollment (A) and at delivery in the peripheral (B) and placental (C) blood samples are presented. Periods covered June 2008 to February 2010 corresponding to the recruitment of the pregnant women and October 2008 to August 2010 for the data collection at delivery.</p
    corecore